Announcing our 10th Peer-Reviewed Published Study

Apr 03 2023

Testing CELLIANT® through clinical trials designed by our Science Advisory Board is critical to our commitment to transparency and demonstrating CELLIANT’s efficacy. We’re very proud to announce our 10th published study, now published in Journal of Textile Science & Engineering and titled, Randomized Placebo-Controlled Clinical Trial of Gloves and Stockings Made from Infrared-Emitting Fabric (Celliant®) for Transcutaneous Oxygen and Peripheral Blood Flow in Diabetic Patients with Vascular Impairment.

This study explores the impact of CELLIANT on diabetic patients with vascular impairment and warrants further research to draw more connections and conclusions between infrared therapies for diabetic patients. This is very exciting for us, because positively impacting the diabetic community has always been a priority for CELLIANT® and an area where we believe our technology could help improve lives. This study is the starting point for demonstrating it, and an area we look forward to continuing to expand our research footprint within.

What is Diabetes?

Diabetes is a chronic health condition in which the body doesn’t make enough insulin or use it as effectively as it should, causing blood sugar to stay in the bloodstream instead of being used by the cells for energy. Over time, this causes very serious health problems. Diabetes is also very widespread with approximately 37.3 million American having the disease and approximately 537 million adults worldwide.

What are some of the symptoms of diabetes?

The most common symptoms of diabetes are:

Urinating more than normal, often at night
Extreme thirst
Severe hunger
Unintentional weight loss
Blurry vision
Numb or tingling hands or feet
Extreme fatigue
Very dry skin
Sores that heal slowly
More infections than usual

What did our study on the effects of CELLIANT for diabetic patients with vascular impairment show?

Diabetic patients often suffer from peripheral neuropathy and peripheral artery disease, which predominantly affect the feet. This means there is less blood flow to the feet, and that combined with the increased blood sugar in the bloodstream, leads to at least three of the symptoms noted above: numb or tingling feet, sores on the feet that heal slowly, and those sores being infected more easily.

While we must emphasize that the sample size of this study was small, the study results indicated that some patients saw an increase of as much as 20% in tissue oxygenation and 30% in localized blood flow. These results are encouraging and mean that the effects of CELLIANT on diabetic patients with vascular impairment warrant further research.

Our Continued Commitment

As the conclusion in the study states:

The trends that were observed in favor of CELLIANT stockings suggest that a larger well-designed clinical trial should be undertaken, and may provide evidence of clinical efficacy in treatment of the diabetic foot.

Hologenix has embarked on a more comprehensive trial, “Study to Evaluate CELLIANT Diabetic Medical Socks to Increase Tissue Oxygenation and Incidence of Complete Wound Closure in Diabetic Foot Wounds – NCT04709419, which focuses on the impact of CELLIANT to potentially technology to improve tissue oxygenation and wound healing outcomes. As we continue our commitment and build on our research, we look forward to sharing the results with our audience once available.

Read the Study

You can read the full study here, or visit our Clinical Trials page to download our library of clinical trial reports for all 10 of our peer-reviewed, published studies.

Get in Touch

We encourage anyone in the field of diabetic research and treatment who is also interested in the potential for infrared textiles to help people with diabetes, to reach out to our team via hello@celliant.com and discuss our hypotheses, outcomes and research protocols.